03:38 PM EDT, 04/18/2024 (MT Newswires) -- Health care stocks were mixed late Thursday afternoon with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.

The iShares Biotechnology ETF (IBB) fell 0.7%.

In corporate news, TG Therapeutics ( TGTX ) shares gained 2.7% after the company won a contract potentially worth $186.8 million for Briumvi to be the preferred anti-CD20 agent listed on the US Department of Veterans Affairs' National Formulary to treat people with multiple sclerosis.